You are here

  • Home
  • Archive
  • Volume 3, Issue 1
  • The therapeutic promise of disrupting the PD-1/PD-L1 immune checkpoint in cancer: unleashing the CD8 T cell mediated anti-tumor activity results in significant, unprecedented clinical efficacy in various solid tumors

Article metrics

Article menu

Download PDFPDF

Commentary
The therapeutic promise of disrupting the PD-1/PD-L1 immune checkpoint in cancer: unleashing the CD8 T cell mediated anti-tumor activity results in significant, unprecedented clinical efficacy in various solid tumors

 

Online download statistics by month:

Online download statistics by month: December 2019 to March 2024

AbstractFullPdf
Dec 2019220
Jan 2020110
Feb 2020661
Mar 202012123
Apr 2020440
May 202017172
Jun 2020880
Jul 2020770
Aug 2020440
Sep 202017170
Oct 202017187
Nov 202014131
Dec 2020883
Jan 2021770
Feb 202114145
Mar 2021550
Apr 202167673
May 202115150
Jun 202116160
Jul 202111112
Aug 2021550
Sep 202112122
Oct 2021883
Nov 202116160
Dec 202111111
Jan 202215161
Feb 202214141
Mar 202216161
Apr 202217184
May 202224241
Jun 202226274
Jul 202222235
Aug 202226261
Sep 202222221
Oct 202229293
Nov 2022202213
Dec 202224243
Jan 202325251
Feb 202326262
Mar 2023181911
Apr 2023772
May 202311116
Jun 2023993
Jul 202312126
Aug 202313155
Sep 202313134
Oct 202310103
Nov 202313134
Dec 202320207
Jan 202418195
Feb 202412126
Mar 202418185
Total784794141